Elanco Animal Health (ELAN) Revenue Growth (1y) (2018 - 2026)

Elanco Animal Health (ELAN) Revenue Growth (1y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (1y) (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 2.34%
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 2.91%
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn -1.62%
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 6.98%
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 42.25%
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 14.92%
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -87.11%
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 1.23%
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn 3.77%
10 Liquidia 5.74 Bn 5.52 Bn 121.79 Mn 4,158.49%

Historic Data

Download Data
DateValue
Mar 31, 2026 14.92%
Dec 31, 2025 12.16%
Sep 30, 2025 10.39%
Jun 30, 2025 4.81%
Mar 31, 2025 -1.00%
Dec 31, 2024 -1.45%
Sep 30, 2024 -3.56%
Jun 30, 2024 12.02%
Mar 31, 2024 -4.14%
Dec 31, 2023 5.08%
Sep 30, 2023 4.09%
Jun 30, 2023 -10.04%
Mar 31, 2023 2.53%
Dec 31, 2022 -11.42%
Sep 30, 2022 -9.28%
Jun 30, 2022 -8.06%
Mar 31, 2022 -1.37%
Dec 31, 2021 -2.43%
Sep 30, 2021 27.08%
Jun 30, 2021 118.09%